Holen Sie sich die Stockscreener-App
2.23
0.45%
-0.01
Schlusskurs vom Vortag:
$2.24
Offen:
$2.215
24-Stunden-Volumen:
96,463
Relative Volume:
1.54
Marktkapitalisierung:
$8.24M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-5.76M
KGV:
-1.2073
EPS:
-1.8471
Netto-Cashflow:
$-5.59M
1W Leistung:
+4.69%
1M Leistung:
+0.00%
6M Leistung:
+0.45%
1J Leistung:
-10.80%
1-Tages-Spanne:
$2.21
$2.32
1-Wochen-Bereich:
$2.11
$2.49
52-Wochen-Spanne:
$1.504
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Firmenname
Creative Medical Technology Holdings Inc
Sektor
Branche
Telefon
480-399-2822
Adresse
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.23 | 8.24M | 3,000 | -5.76M | -5.59M | -1.8471 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Creative Medical Technology Holdings Inc Aktie (CELZ) Neueste Nachrichten
Creative Medical Technology Holdings Inc (CELZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Creative Medical Technology Holdings Inc - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Institutional Confidence - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Creative Medical Technology Holdings Expands Project PHOENIX to Collect Health Data from Veterans Exposed to Toxic Hazards - geneonline.com
Creative Medical launches virtual platform for veteran burn pit study By Investing.com - Investing.com South Africa
CELZ Advances Project PHOENIX into Data Collection Phase - GuruFocus
Creative Medical Technology opens nationwide burn-pit data registry - Proactive financial news
Creative Medical Technology (CELZ) Slips 4.6% as Stock Approaches Key SupportDay Trade Opportunities - newsline.com
Small cap wrap: Blockmate Ventures, Aftermath Silver, Arizona Gold & Silver… - Proactive financial news
Creative Medical Technology Holdings Advances Project Phoenix into Nationwide Ai Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards - marketscreener.com
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards - The Manila Times
AI project to map toxic burn pit exposure in 1,000 US veterans - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market SessionAlvotech (NASDAQ:ALVO), Anixa Biosciences - Benzinga
CELZ Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesFull Year Guidance - newsline.com
Anthropic Quietly Releases Claude Fable 5 to Public After Earlier ConcernsPreliminary Results - newsline.com
Hancock Whitney Q1 2026 Earnings: EPS Beats Estimates Modestly Amid Flat Revenue EnvironmentOperating Margin Analysis - newsline.com
CELZ Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentEarnings Revision Report - newsline.com
Spain Tourism Surges to Record as Travelers Shift from Middle EastShort-Term Outlook - newsline.com
Nuwellis Shares Sink After Pricing $6 Million Equity and Warrant Offering (NUWE) - Yahoo Finance
Pro-Dex Inc. (PDEX) Edges Higher as Shares Trade Near ResistanceHedge Fund Favorites - newsline.com
CELZ Q1 2026 Earnings: Loss Per Share Narrows, Topping Analyst EstimatesEarnings Revision Downgrade - The Legal Advocate
CELZ Q1 2026 Earnings: Narrower Q1 Loss Fails to Lift Shares as Market Focuses on Cash RunwayFinancial Health Score - newsline.com
CELZ PE Ratio & Valuation, Is CELZ Overvalued - Intellectia AI
EPS Creative Health Technology Group Limited Announces Management Changes, Effective May 31, 2026 - marketscreener.com
Creative Medical Technology (CELZ) Edges Lower by 0.22% as Stock Consolidates Between Key LevelsStock Surge Alerts - The Legal Advocate
MFA Financial Inc. 8.875% Senior Notes due 2029 (MFAN) Q1 2026 Earnings: EPS Falls Just Short of Estimates, Bond Price Edges HigherProfit Cycle Analysis - The Legal Advocate
MIRA Pharmaceuticals Inc. (MIRA) Slips 8.66% to $1.05 as Technicals Test Key SupportLinear Regression - newsline.com
CELZ Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline AdvancesProfit Guidance Range - The Legal Advocate
Critical Metals Corp (CRML) Slips 3.75% as Key Support Level Tests BuyersRSI Oversold Picks - The Legal Advocate
CELZ Stock Price, Quote & Chart | CREATIVE MEDICAL TECHNOLOGY (NASDAQ:CELZ) - ChartMill
Intercontinental Exchange (ICE) Edges Higher Amid Positive Volume TrendsLast Point Support - newsline.com
Creo Medical shares surge 27% on proposed sale of remaining European stake - Yahoo Finance
Japan Smaller Capitalization Fund (JOF) Edges Lower Amid Modest PullbackMAMA Signal - The Legal Advocate
Creative Medical Technology Holdings, Inc.Common Stock (NQ: CELZ - FinancialContent
Accel Entertainment (ACEL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Xtant Medical Q1 2026 Results: Revenue Guidance Raised, Balance Sheet Strengthened, Exclusive HEMOBLAST® Bellows Distribution Secured 12 - Minichart
QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million - Business Wire
Incannex Healthcare Wins MedTech Breakthrough Award for Innovative Obstructive Sleep Apnea Drug IHL-42X - Minichart
Leading Breast Surgical Oncologist Dr. Barry Roseman to Serve as Senior Medical Advisor to QT Imaging - Business Wire
United States shares higher at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com
CELZ (CreativeMed) EPS beats estimates but shares fall nearly 3% despite narrower losses.AI Stock Signals - Newser
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Creative Medical Technology (NASDAQ: CELZ) posts Q1 2026 loss, details cash use - Stock Titan
How CreativeMed (CELZ) prepares for market disruptions | Q3 2025: Earnings Beat EstimatesTrend Analysis - newser.com
Governor Newsom announces $1B in private investment generated through California Competes Tax Credits, driving business expansion in key industry sectors - California State Portal | CA.gov
Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):